While there isn't a single "best" bacteria for Inflammatory Bowel Disease (IBD) for all individuals, certain Bifidobacterium strains have shown beneficial effects in murine models of DSS-colitis, suggesting potential for IBD management.
Here's what the reference indicates:
- In a mouse model of DSS-colitis, specific Bifidobacterium strains demonstrated positive effects.
- Bifidobacterium animalis subsp. lactis BB12 and Bifidobacterium longum subsp. infantis BB-02 alleviated both susceptibility to and symptoms of the disease.
Therefore, based on this evidence, Bifidobacterium animalis subsp. lactis BB12 and Bifidobacterium longum subsp. infantis BB-02 are potential candidates to consider for IBD management, although these findings are from animal studies and may not directly translate to human outcomes. More research is needed to confirm these benefits in humans.
